Literature DB >> 31079009

Optimization of protein entrapment in affinity microcolumns using hydrazide-activated silica and glycogen as a capping agent.

John Vargas-Badilla1, Saumen Poddar1, Shiden Azaria1, Chenhua Zhang1, David S Hage2.   

Abstract

Several approaches were compared for the entrapment of proteins within hydrazide-activated silica for use in affinity microcolumns and high performance affinity chromatography. Human serum albumin (HSA) and concanavalin A (Con A) were used as model proteins for this work. Items considered in this study included the role played by the solution volume, amount of added protein, and use of slurry vs. on-column entrapment on the levels of solute retention and extent of protein immobilization that could be obtained by means of entrapment. The levels of retention and protein immobilization were evaluated by injecting warfarin or 4-methylumbellipheryl α-D-mannopyranoside as solutes with known binding properties for HSA or Con A. Altering both the solution volume and amount of added protein led to an increase of up to 17-fold in the extent of protein immobilization for HSA in slurry-based entrapment; on-column entrapment provided an additional 3.6-fold increase in protein content vs. the optimized slurry method. Similar general trends were seen for Con A. The protein contents obtained by entrapment for HSA or Con A (i.e., up to ~87 and 46 mg/g silica, respectively) were comparable to or higher than levels reported for the covalent immobilization of these proteins onto silica. The retention of warfarin on the entrapped HSA was at least 1.7-fold higher than has been obtained under comparable support and mobile phase conditions when using covalent immobilization. These results indicated that entrapment can be an attractive alternative to covalent immobilization for proteins such as HSA and Con A, with this approach serving as a potential means for obtaining good solute binding and retention in work with affinity microcolumns or related microscale devices.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affinity microcolumn; Concanavalin A; Entrapment; High performance affinity chromatography; Human serum albumin; Protein immobilization

Mesh:

Substances:

Year:  2019        PMID: 31079009      PMCID: PMC6545136          DOI: 10.1016/j.jchromb.2019.05.004

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  29 in total

1.  Predicting plasma protein binding of drugs: a new approach.

Authors:  Nicole A Kratochwil; Walter Huber; Francis Müller; Manfred Kansy; Paul R Gerber
Journal:  Biochem Pharmacol       Date:  2002-11-01       Impact factor: 5.858

2.  The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation.

Authors:  J K Armstrong; R B Wenby; H J Meiselman; T C Fisher
Journal:  Biophys J       Date:  2004-09-10       Impact factor: 4.033

3.  Development of sulfhydryl-reactive silica for protein immobilization in high-performance affinity chromatography.

Authors:  Rangan Mallik; Chunling Wa; David S Hage
Journal:  Anal Chem       Date:  2007-02-15       Impact factor: 6.986

4.  Entrapment of proteins in glycogen-capped and hydrazide-activated supports.

Authors:  Abby J Jackson; Hai Xuan; David S Hage
Journal:  Anal Biochem       Date:  2010-05-12       Impact factor: 3.365

Review 5.  Bioinspired enzyme encapsulation for biocatalysis.

Authors:  Lorena Betancor; Heather R Luckarift
Journal:  Trends Biotechnol       Date:  2008-08-29       Impact factor: 19.536

6.  Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC).

Authors:  Hee Seung Kim; Irving W Wainer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-05-24       Impact factor: 3.205

7.  Chromatographic analysis of carbamazepine binding to human serum albumin. II. Comparison of the Schiff base and N-hydroxysuccinimide immobilization methods.

Authors:  Hee Seung Kim; Rangan Mallik; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-05-09       Impact factor: 3.205

8.  Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding.

Authors:  Michelle J Yoo; John E Schiel; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-04-24       Impact factor: 3.205

9.  Development and evaluation of N-hydroxysuccinimide-activated silica for immobilizing human serum albumin in liquid chromatography columns.

Authors:  Hee Seung Kim; Young Sik Kye; David S Hage
Journal:  J Chromatogr A       Date:  2004-09-17       Impact factor: 4.759

10.  Combining lectin microcolumns with high-resolution separation techniques for enrichment of glycoproteins and glycopeptides.

Authors:  Milan Madera; Yehia Mechref; Milos V Novotny
Journal:  Anal Chem       Date:  2005-07-01       Impact factor: 6.986

View more
  4 in total

Review 1.  Affinity chromatography: A review of trends and developments over the past 50 years.

Authors:  Elliott L Rodriguez; Saumen Poddar; Sazia Iftekhar; Kyungah Suh; Ashley G Woolfork; Susan Ovbude; Allegra Pekarek; Morgan Walters; Shae Lott; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2020-08-14       Impact factor: 3.205

2.  Development of an on-line immunoextraction/entrapment system for protein capture and use in drug binding studies by high-performance affinity chromatography.

Authors:  Elliott L Rodriguez; Saumen Poddar; Meera Choksi; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-11-30       Impact factor: 3.205

Review 3.  [Advances in chromatography in the study of drug-plasma protein interactions].

Authors:  Yu Bai; Yufan Fan; Guangbo Ge; Fangjun Wang
Journal:  Se Pu       Date:  2021-10

4.  Recent Advances in Supramolecular Affinity Separations: Affinity Chromatography and Related Methods.

Authors:  Ashley G Woolfork; Sazia Iftekhar; Susan Ovbude; Kyungah Suh; Sadia Sharmeen; Isaac Kyei; Jacob Jones; David S Hage
Journal:  Adv Chromatogr       Date:  2021       Impact factor: 0.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.